190 related articles for article (PubMed ID: 22044500)
1. Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.
Schill T; Schön MP; Pletz N; Emmert S; Schön M
Exp Dermatol; 2012 Feb; 21(2):91-8. PubMed ID: 22044500
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injury.
Grote K; Sonnenschein K; Kapopara PR; Hillmer A; Grothusen C; Salguero G; Kotlarz D; Schuett H; Bavendiek U; Schieffer B
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2097-104. PubMed ID: 23868938
[TBL] [Abstract][Full Text] [Related]
3. Local pulmonary immune stimulation by the Toll-like receptor 2 and 6 ligand MALP-2 in rats is age dependent.
Lührmann A; Grote K; Stephan M; Tschernig T; Pabst R
Immunol Lett; 2007 Feb; 108(2):167-73. PubMed ID: 17275100
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of TLR-2/6 ligation in pulmonary bacterial infection and immunization with Pseudomonas aeruginosa.
Kerber-Momot T; Leemhuis D; Lührmann A; Munder A; Tümmler B; Pabst R; Tschernig T
Inflammation; 2010 Feb; 33(1):58-64. PubMed ID: 19844782
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regeneration.
Grote K; Schuett H; Salguero G; Grothusen C; Jagielska J; Drexler H; Mühlradt PF; Schieffer B
Blood; 2010 Mar; 115(12):2543-52. PubMed ID: 20056792
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells.
Schuett J; Schuett H; Oberoi R; Koch AK; Pretzer S; Luchtefeld M; Schieffer B; Grote K
FASEB J; 2017 Jun; 31(6):2612-2624. PubMed ID: 28274989
[TBL] [Abstract][Full Text] [Related]
8. Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2.
Sawahata R; Shime H; Yamazaki S; Inoue N; Akazawa T; Fujimoto Y; Fukase K; Matsumoto M; Seya T
Microbes Infect; 2011 Apr; 13(4):350-8. PubMed ID: 21172450
[TBL] [Abstract][Full Text] [Related]
9. Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia.
Reppe K; Tschernig T; Lührmann A; van Laak V; Grote K; Zemlin MV; Gutbier B; Müller HC; Kursar M; Schütte H; Rosseau S; Pabst R; Suttorp N; Witzenrath M
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):474-81. PubMed ID: 18931326
[TBL] [Abstract][Full Text] [Related]
10. The Lipopeptide MALP-2 Promotes Collateral Growth.
Troidl K; Schubert C; Vlacil AK; Chennupati R; Koch S; Schütt J; Oberoi R; Schaper W; Schmitz-Rixen T; Schieffer B; Grote K
Cells; 2020 Apr; 9(4):. PubMed ID: 32316253
[TBL] [Abstract][Full Text] [Related]
11. A Toll-like receptor 2/6 agonist reduces allergic airway inflammation in chronic respiratory sensitisation to Timothy grass pollen antigens.
Fuchs B; Knothe S; Rochlitzer S; Nassimi M; Greweling M; Lauenstein HD; Nassenstein C; Müller M; Ebensen T; Dittrich AM; Krug N; Guzman CA; Braun A
Int Arch Allergy Immunol; 2010; 152(2):131-9. PubMed ID: 20016195
[TBL] [Abstract][Full Text] [Related]
12. Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes.
Wilde I; Lotz S; Engelmann D; Starke A; van Zandbergen G; Solbach W; Laskay T
Med Microbiol Immunol; 2007 Jun; 196(2):61-71. PubMed ID: 17006695
[TBL] [Abstract][Full Text] [Related]
13. Fever induction by systemic stimulation with macrophage-activating lipopeptide-2 depends upon TLR2 but not CD36.
Welsch J; Hübschle T; Murgott J; Kirschning C; Rummel C; Gerstberger R; Roth J
Innate Immun; 2012 Jun; 18(3):541-59. PubMed ID: 22042912
[TBL] [Abstract][Full Text] [Related]
14. The TLR-2/TLR-6 agonist macrophage-activating lipopeptide-2 augments human NK cell cytotoxicity when PGE2 production by monocytes is inhibited by a COX-2 blocker.
Müller C; Tufa DM; Chatterjee D; Mühlradt PF; Schmidt RE; Jacobs R
Cancer Immunol Immunother; 2015 Sep; 64(9):1175-84. PubMed ID: 26036909
[TBL] [Abstract][Full Text] [Related]
15. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.
Nobumoto A; Nagahara K; Oomizu S; Katoh S; Nishi N; Takeshita K; Niki T; Tominaga A; Yamauchi A; Hirashima M
Glycobiology; 2008 Sep; 18(9):735-44. PubMed ID: 18579572
[TBL] [Abstract][Full Text] [Related]
16. Effects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungs.
Barrenschee M; Lex D; Uhlig S
PLoS One; 2010 Nov; 5(11):e13889. PubMed ID: 21124967
[TBL] [Abstract][Full Text] [Related]
17. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.
Borsutzky S; Kretschmer K; Becker PD; Mühlradt PF; Kirschning CJ; Weiss S; Guzmán CA
J Immunol; 2005 May; 174(10):6308-13. PubMed ID: 15879130
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-activating lipopeptide-2 (MALP-2) induces a localized inflammatory response in rats resulting in activation of brain sites implicated in fever.
Knorr C; Hübschle T; Murgott J; Mühlradt P; Gerstberger R; Roth J
Brain Res; 2008 Apr; 1205():36-46. PubMed ID: 18353287
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-activating lipopeptide-2 exerts protective effects in a murine sepsis model.
Zeckey C; Tschernig T; Hildebrand F; Frink M; Frömke C; Dorsch M; Krettek C; Barkhausen T
Shock; 2010 Jun; 33(6):614-9. PubMed ID: 19940812
[TBL] [Abstract][Full Text] [Related]
20. Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.
Schmidt J; Welsch T; Jäger D; Mühlradt PF; Büchler MW; Märten A
Br J Cancer; 2007 Sep; 97(5):598-604. PubMed ID: 17667928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
